Tesla (TSLA) › Analysis

Tesla (TSLA) stock analysis, March 19, 2026: Tesla tests $380 after $300B Terafab capex plan breaks $390 support

Published March 19, 2026 · TSLA chart, levels and live analysis

Key Updates

Tesla shares declined -4.30% to $382.19 since the March 17 report, breaking below the $390 support level and extending YTD losses to -15.02%. The selloff accelerated despite positive analyst sentiment, driven by mounting concerns over the company's unprecedented capital expenditure plans. The Terafab Project announcement revealed capital requirements potentially reaching $300 billion at full capacity, significantly exceeding initial market expectations and raising concerns about Tesla's first negative free cash flow since 2018, projected at -$4.1 billion for 2026.

Current Trend

Tesla shares are in a pronounced downtrend with YTD losses of -15.02%, significantly underperforming the broader market. The stock has broken through multiple support levels, declining -10.30% over six months and -6.93% over one month. The $400 psychological threshold, which provided resistance in previous reports, now represents overhead resistance approximately 4.7% above current levels. The $390 level failed to provide support, and shares are now testing the $380 zone. Short-term momentum remains negative across all timeframes (1-day: -2.70%, 5-day: -3.25%), indicating persistent selling pressure despite brief rallies following positive analyst coverage earlier in March.

Investment Thesis

The investment thesis centers on Tesla's transformation from an electric vehicle manufacturer into a diversified AI and autonomous technology company. Bank of America's analysis values the autonomous vehicle and robotaxi businesses at $735 billion, more than double the $345 billion attributed to the EV division, with the robotaxi business alone valued at $422 billion and Full Self-Driving software at $313 billion. The company's camera-only approach to autonomous driving offers a significant cost advantage over competitors' multi-sensor systems, with projected costs of $1.58 per mile versus $3.41 for traditional ride-sharing services. Additional value drivers include the Optimus humanoid robot segment (valued over $30 billion) and the energy business ($90 billion). However, this thesis now requires validation through successful execution of massive capital deployment while navigating regulatory challenges, declining EV sales, and the transition to subscription-based revenue models.

Thesis Status

The investment thesis faces significant near-term execution risk despite maintaining long-term strategic validity. The Terafab Project announcement confirms management's commitment to vertical integration in AI chip manufacturing, but the scale of capital requirements—$20 billion in 2026 excluding Terafab, with potential total costs reaching $300 billion—substantially exceeds previous expectations. The projected negative free cash flow of -$4.1 billion in 2026 marks a critical inflection point, representing the first negative FCF since 2018 and raising questions about financing strategy and balance sheet impact. Operationally, robotaxi expansion remains on track with services in two cities and seven additional markets planned for 2026, but the 14 crashes in Austin since June highlight persistent safety and regulatory challenges. The resolution of California marketing disputes removes a significant operational risk, but only 1.1 million of 8.9 million vehicles sold have purchased FSD subscriptions, indicating substantial adoption challenges ahead of BofA's 8.7 million customer target by 2030.

Key Drivers

Terafab Project and Capital Intensity: The announcement of the Terafab Project launching in 7 days represents Tesla's entry into logic and memory chip manufacturing, with Musk citing insufficient capacity from current partners TSMC, Samsung, and Micron. UBS estimates initial costs at $30 billion with potential expansion to $300 billion at full production capacity. Combined with $20 billion in other capex for 2026, Tesla enters its most capital-intensive phase since inception, with Wall Street projecting negative FCF of -$4.1 billion for 2026.

Robotaxi Valuation and Expansion: Bank of America assigns 54% of Tesla's total valuation to its robotaxi business, more than double the 21% attributed to core automotive operations. The firm projects Tesla could capture up to 50% of the global robotaxi market, with Morgan Stanley forecasting 5 million robotaxis by 2035 versus 1,000 expected by end of 2026. Tesla plans to expand from two cities to nine in 2026, though the Austin service has experienced 14 crashes since June, highlighting operational and regulatory challenges.

FSD Adoption and Regulatory Resolution: Tesla resolved its California marketing dispute by discontinuing use of "Autopilot" terminology and eliminating the $8,000 upfront FSD purchase option in favor of a $99 monthly subscription model. While this removes the threat of a 30-day sales suspension in Tesla's largest market, only 1.1 million of 8.9 million vehicles sold have FSD subscriptions, requiring substantial growth to reach BofA's projection of 8.7 million FSD customers by 2030. Regulatory approval in China and Europe remains pending.

Analyst Sentiment Divergence: Bank of America upgraded Tesla to buy with a $460-$488 price target, representing 17-28% upside from current levels, citing leadership in autonomous driving and additional value from Optimus robots ($30+ billion) and energy business ($90 billion). However, the stock's -4.30% decline since the upgrade suggests market skepticism about near-term execution risk and capital allocation concerns outweighing long-term strategic positioning.

Technical Analysis

Tesla shares are trading at $382.19, down -4.30% since the March 17 report and -15.02% year-to-date, establishing a clear downtrend across all timeframes. The stock has broken below the $390 support level that briefly held in mid-March and is now testing the $380 zone. The $400 psychological level, which provided resistance during previous rallies, now represents overhead resistance 4.7% above current prices. Near-term resistance is established at $390-$395, while support appears at $375-$380. The consistent negative momentum across 1-day (-2.70%), 5-day (-3.25%), 1-month (-6.93%), and 6-month (-10.30%) periods indicates sustained selling pressure. The stock's inability to hold gains following positive analyst coverage suggests technical weakness and investor skepticism about fundamental catalysts. The 6-month decline of -10.30% has accelerated in recent weeks, with the 1-month loss of -6.93% indicating deteriorating momentum. Key resistance levels to monitor are $390 (near-term), $400 (psychological), and $410-$415 (previous consolidation zone), while support levels are $380 (current test), $370, and $350 (6-month lows).

Bull Case

Bear Case

Get a message when the TSLA picture changes — the agent team watches the levels and the news for you.Create a free account

More TSLA analyses